Zosano Pharma Corporation (NASDAQ: ZSAN) announced the publication of Phase 1 trial data of influenza vaccine in the Journal of Vaccines and Immunology. The data demonstrated that a low dose of a ...

Merck & Co. and vaccine delivery specialist Vaxxas started a research collaboration focused on evaluating the use of the latter’s transdermal Nanopatch™ vaccine delivery system with a Merck vaccine ...

Fremont, CA-based Zosano Pharma has received $45 million in its second round, bringing its total funding thus far to $90 million. Enterprise Associates, Nomura Phase4 Ventures, HBM BioVentures and ...

Mundelein, Ill.-based Medline is launching a newly designed skin adhesive at the 2014 Association of periOperative Registered Nurses surgical conference and exposition. The adhesive, Surgiseal Twist, ...